ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GLYC GlycoMimetics Inc

2.80
0.00 (0.00%)
Pre Market
Last Updated: 04:00:17
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 2.60
Ask Price 3.25
News -
Day High

Low
1.11

52 Week Range

High
3.5299

Day Low
Company Name Stock Ticker Symbol Market Type
GlycoMimetics Inc GLYC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 2.80 04:00:17
Open Price Low Price High Price Close Price Prev Close
2.80
Trades Volume Avg Volume 52 Week Range
0 0 - 1.11 - 3.5299
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 2.80 USD

GlycoMimetics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
180.3M 64.39M - 75k -46.69M -0.73 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

GlycoMimetics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No GLYC Message Board. Create One! See More Posts on GLYC Message Board See More Message Board Posts

Historical GLYC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.522.872.502.64327,4630.2811.11%
1 Month3.203.362.502.84277,586-0.40-12.50%
3 Months2.563.52992.202.97341,8780.249.37%
6 Months1.413.52991.112.49243,4411.3998.58%
1 Year1.393.52991.112.11222,1721.41101.44%
3 Years3.374.160.512.13438,490-0.57-16.91%
5 Years12.5513.560.513.15475,198-9.75-77.69%

GlycoMimetics Description

GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection.

Your Recent History

Delayed Upgrade Clock